{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/27/3352397/0/en/outlook-therapeutics-appoints-kevin-lundquist-as-chief-financial-officer-as-it-prepares-for-u-s-commercial-launch-of-lytenava.html", "message": "News view counter 905773 successfully enlarged"}